362 related articles for article (PubMed ID: 20298289)
1. Does tumour necrosis factor-alpha inhibitor infliximab induce histological resolution of pulmonary sarcoid granulomas?
Milman N; Andersen CB; Baslund B; Loft A; Iversen M
Clin Respir J; 2007 Dec; 1(2):106-13. PubMed ID: 20298289
[TBL] [Abstract][Full Text] [Related]
2. Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity.
Shamaei M; Mortaz E; Pourabdollah M; Garssen J; Tabarsi P; Velayati A; Adcock IM
Hum Immunol; 2018 Jan; 79(1):63-69. PubMed ID: 29107084
[TBL] [Abstract][Full Text] [Related]
3. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
[TBL] [Abstract][Full Text] [Related]
4. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosis].
Olivier A; Gilson B; Lafontaine S; Pautot JX; Bindi P
Rev Med Interne; 2012 May; 33(5):e25-7. PubMed ID: 21592629
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis.
Galli F; Lanzolla T; Pietrangeli V; Malviya G; Ricci A; Bruno P; Ragni P; Scopinaro F; Mariotta S; Signore A
Biomed Res Int; 2015; 2015():401341. PubMed ID: 25866780
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis is a major cause of so-called "caseous necrosis" in mycobacterial granulomas in HIV-infected patients.
Leong AS; Wannakrairot P; Leong TY
J Clin Pathol; 2008 Mar; 61(3):366-72. PubMed ID: 17761737
[TBL] [Abstract][Full Text] [Related]
8. [Granulomatous diseases and pathogenic microorganism].
Inoue Y; Suga M
Kekkaku; 2008 Feb; 83(2):115-30. PubMed ID: 18326339
[TBL] [Abstract][Full Text] [Related]
9. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis.
Fehrenbach H; Zissel G; Goldmann T; Tschernig T; Vollmer E; Pabst R; Müller-Quernheim J
Eur Respir J; 2003 Mar; 21(3):421-8. PubMed ID: 12661995
[TBL] [Abstract][Full Text] [Related]
10. Transbronchial biopsy in sarcoidosis: the role of immunohistochemical analysis for granuloma detection.
Menestrina F; Lestani M; Mombello A; Cipriani A; Pomponi F; Adami F; Semenzato G; Chilosi M
Sarcoidosis; 1992 Sep; 9(2):95-100. PubMed ID: 1285342
[TBL] [Abstract][Full Text] [Related]
11. Isolated dysphagia unmasking bulbar neurosarcoidosis and pulmonary sarcoidosis.
Abdallah T; Abdallah M; Elsayegh D; Chalhoub M; Khoueiry G; Glatman A; Maniatis T
Arab J Gastroenterol; 2014 Jun; 15(2):85-7. PubMed ID: 25097053
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis.
Ishioka S; Saito T; Hiyama K; Haruta Y; Maeda A; Hozawa S; Inamizu T; Yamakido M
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Sep; 13(2):139-45. PubMed ID: 8893383
[TBL] [Abstract][Full Text] [Related]
13. Cellular and Cytokine Responses in the Granulomas of Asymptomatic Cattle Naturally Infected with Mycobacterium bovis in Ethiopia.
Tulu B; Martineau HM; Zewude A; Desta F; Jolliffe DA; Abebe M; Balcha TT; Belay M; Martineau AR; Ameni G
Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32958527
[TBL] [Abstract][Full Text] [Related]
14. End-stage sarcoid lung disease is distinct from usual interstitial pneumonia.
Xu L; Kligerman S; Burke A
Am J Surg Pathol; 2013 Apr; 37(4):593-600. PubMed ID: 23426125
[TBL] [Abstract][Full Text] [Related]
15. ⁹⁹mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosis.
Vis R; Malviya G; Signore A; Grutters JC; Meek B; van de Garde EM; Keijsers RG
Eur Respir J; 2016 Apr; 47(4):1198-207. PubMed ID: 26797030
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.
Keijsers RG; Verzijlbergen JF; van Diepen DM; van den Bosch JM; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):143-9. PubMed ID: 19382534
[TBL] [Abstract][Full Text] [Related]
17. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
[TBL] [Abstract][Full Text] [Related]
18. Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium.
Negi M; Takemura T; Guzman J; Uchida K; Furukawa A; Suzuki Y; Iida T; Ishige I; Minami J; Yamada T; Kawachi H; Costabel U; Eishi Y
Mod Pathol; 2012 Sep; 25(9):1284-97. PubMed ID: 22596102
[TBL] [Abstract][Full Text] [Related]
19. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature.
Thatayatikom A; Thatayatikom S; White AJ
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):293-300. PubMed ID: 16200822
[TBL] [Abstract][Full Text] [Related]
20. Infliximab for treating sarcoidosis patients, Portuguese experience.
Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
